A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the ...
Running I test running shoes, and if you need a cushioned sneaker for marathon training, the Nike Vomero Plus is my top pick — here’s why Running I ran 35 miles in the Puma MagMax Nitro 2 — here's my ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
Anchor your business to a stubborn, real-world problem customers cannot ignore. Replace hustle with systems that standardize decisions, data flow and accountability. Ambition isn’t what holds ...
Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...
Changing the legal structure of a business is a pivotal moment in an entrepreneur’s journey, requiring both careful planning and a deep understanding of the potential legal, financial and operational ...
Official support for free-threaded Python, and free-threaded improvements Python’s free-threaded build promises true parallelism for threads in Python programs by removing the Global Interpreter Lock ...
Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...
What if the programming language you rely on most is on the brink of a transformation? For millions of developers worldwide, Python is not just a tool, it’s a cornerstone of their craft, powering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results